Posttreatment Management of Cushing's Disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Transsphenoidal surgery is the first-line treatment for Cushing's disease. Successful removal of the adrenocorticotropic hormone-secreting pituitary tumor requires cautious follow-up because of the postoperative onset of adrenal insufficiency. Furthermore, possible surgical complications, such as diabetes insipidus and pituitary insufficiency, may occur. Despite an overall remission rate between 25% and 100% after primary surgery, disease persistence and recurrence are yet major clinical problems, and second-line therapies (alone or in combination) have to be considered, such as a wait-and-see approach, repeated neurosurgery, radiotherapy, radiosurgery, medical therapy, or adrenal surgery. Each of these approaches has strengths and limitations, and the choice has to be tailored to each clinical case, according to clinical, biochemical, and radiological data. Finally, despite persistent remission, long-term effects of hypercortisolism can affect the cardiovascular system as well as the skeletal system and the brain, with detrimental long-term sequelae.

Original languageEnglish (US)
Title of host publicationCushing's Disease
Subtitle of host publicationAn Often Misdiagnosed and Not So Rare Disorder
PublisherElsevier Inc.
Pages135-167
Number of pages33
ISBN (Electronic)9780128043905
ISBN (Print)9780128043400
DOIs
StatePublished - Nov 14 2016

Fingerprint

Pituitary ACTH Hypersecretion
Adrenal Insufficiency
Hypopituitarism
Diabetes Insipidus
Cushing Syndrome
Radiosurgery
Neurosurgery
Pituitary Neoplasms
Cardiovascular System
Adrenocorticotropic Hormone
Radiotherapy
Therapeutics
Recurrence
Brain

Keywords

  • Adrenal insufficiency
  • Adrenalectomy
  • Crooke's cell
  • Cushing's disease
  • Diabetes insipidus
  • Hypercortisolism
  • Hypopituitarism
  • Nelson's syndrome
  • Radiosurgery

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prete, A., & Salvatori, R. (2016). Posttreatment Management of Cushing's Disease. In Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder (pp. 135-167). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-804340-0.00009-7

Posttreatment Management of Cushing's Disease. / Prete, A.; Salvatori, Roberto.

Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc., 2016. p. 135-167.

Research output: Chapter in Book/Report/Conference proceedingChapter

Prete, A & Salvatori, R 2016, Posttreatment Management of Cushing's Disease. in Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc., pp. 135-167. https://doi.org/10.1016/B978-0-12-804340-0.00009-7
Prete A, Salvatori R. Posttreatment Management of Cushing's Disease. In Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc. 2016. p. 135-167 https://doi.org/10.1016/B978-0-12-804340-0.00009-7
Prete, A. ; Salvatori, Roberto. / Posttreatment Management of Cushing's Disease. Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc., 2016. pp. 135-167
@inbook{c5e04529c78b42a5a7e0da29497d9a88,
title = "Posttreatment Management of Cushing's Disease",
abstract = "Transsphenoidal surgery is the first-line treatment for Cushing's disease. Successful removal of the adrenocorticotropic hormone-secreting pituitary tumor requires cautious follow-up because of the postoperative onset of adrenal insufficiency. Furthermore, possible surgical complications, such as diabetes insipidus and pituitary insufficiency, may occur. Despite an overall remission rate between 25{\%} and 100{\%} after primary surgery, disease persistence and recurrence are yet major clinical problems, and second-line therapies (alone or in combination) have to be considered, such as a wait-and-see approach, repeated neurosurgery, radiotherapy, radiosurgery, medical therapy, or adrenal surgery. Each of these approaches has strengths and limitations, and the choice has to be tailored to each clinical case, according to clinical, biochemical, and radiological data. Finally, despite persistent remission, long-term effects of hypercortisolism can affect the cardiovascular system as well as the skeletal system and the brain, with detrimental long-term sequelae.",
keywords = "Adrenal insufficiency, Adrenalectomy, Crooke's cell, Cushing's disease, Diabetes insipidus, Hypercortisolism, Hypopituitarism, Nelson's syndrome, Radiosurgery",
author = "A. Prete and Roberto Salvatori",
year = "2016",
month = "11",
day = "14",
doi = "10.1016/B978-0-12-804340-0.00009-7",
language = "English (US)",
isbn = "9780128043400",
pages = "135--167",
booktitle = "Cushing's Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Posttreatment Management of Cushing's Disease

AU - Prete, A.

AU - Salvatori, Roberto

PY - 2016/11/14

Y1 - 2016/11/14

N2 - Transsphenoidal surgery is the first-line treatment for Cushing's disease. Successful removal of the adrenocorticotropic hormone-secreting pituitary tumor requires cautious follow-up because of the postoperative onset of adrenal insufficiency. Furthermore, possible surgical complications, such as diabetes insipidus and pituitary insufficiency, may occur. Despite an overall remission rate between 25% and 100% after primary surgery, disease persistence and recurrence are yet major clinical problems, and second-line therapies (alone or in combination) have to be considered, such as a wait-and-see approach, repeated neurosurgery, radiotherapy, radiosurgery, medical therapy, or adrenal surgery. Each of these approaches has strengths and limitations, and the choice has to be tailored to each clinical case, according to clinical, biochemical, and radiological data. Finally, despite persistent remission, long-term effects of hypercortisolism can affect the cardiovascular system as well as the skeletal system and the brain, with detrimental long-term sequelae.

AB - Transsphenoidal surgery is the first-line treatment for Cushing's disease. Successful removal of the adrenocorticotropic hormone-secreting pituitary tumor requires cautious follow-up because of the postoperative onset of adrenal insufficiency. Furthermore, possible surgical complications, such as diabetes insipidus and pituitary insufficiency, may occur. Despite an overall remission rate between 25% and 100% after primary surgery, disease persistence and recurrence are yet major clinical problems, and second-line therapies (alone or in combination) have to be considered, such as a wait-and-see approach, repeated neurosurgery, radiotherapy, radiosurgery, medical therapy, or adrenal surgery. Each of these approaches has strengths and limitations, and the choice has to be tailored to each clinical case, according to clinical, biochemical, and radiological data. Finally, despite persistent remission, long-term effects of hypercortisolism can affect the cardiovascular system as well as the skeletal system and the brain, with detrimental long-term sequelae.

KW - Adrenal insufficiency

KW - Adrenalectomy

KW - Crooke's cell

KW - Cushing's disease

KW - Diabetes insipidus

KW - Hypercortisolism

KW - Hypopituitarism

KW - Nelson's syndrome

KW - Radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=85027165033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027165033&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-804340-0.00009-7

DO - 10.1016/B978-0-12-804340-0.00009-7

M3 - Chapter

AN - SCOPUS:85027165033

SN - 9780128043400

SP - 135

EP - 167

BT - Cushing's Disease

PB - Elsevier Inc.

ER -